Supplementation with high-dose omega-3 improved markers of non-alcoholic fatty liver disease (NAFLD), according to a recent pilot study in European Journal of Clinical Nutrition.
from NutraIngredients RSS http://ift.tt/2eVP0lD
via IFTTT
information on Dietary Supplements
Supplementation with high-dose omega-3 improved markers of non-alcoholic fatty liver disease (NAFLD), according to a recent pilot study in European Journal of Clinical Nutrition.